Latest News and Press Releases

Sanofi’s Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study Nexviazyme met its primary endpoint, participants alive and free of invasive ventilation, in...

LONDON, 30 Jun. 2026 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information...

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 30, 2026 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio...

VALLOUREC AWARDED MAJOR CONTRACT BY AZULE ENERGY FOR THE GREATER PAJ OFFSHORE DEVELOPMENT IN ANGOLA Meudon, on June 30, 2026 – Vallourec, a world leader in premium seamless tubular solutions,...

ORION CORPORATION PRESS RELEASE 30 JUNE 2026 at 8.00 EEST         Orion Pharma announces agreement with Shilpa Medicare for nivolumab biosimilar for European market Orion Pharma (“Orion”) and...

WISeKey Shareholders Approved All Agenda Items of the 2026 Annual General Meeting Geneva, Switzerland, June 30, 2026 – WISeKey International Holding Ltd ("WISeKey") (SIX: WIHN, NASDAQ: WKEY), a...

Press Release Weekly progress on share repurchase program to cover share plans and reduce capital Kaiseraugst (Switzerland), Maastricht (Netherlands), June 30, 2026 dsm-firmenich, innovators in...

Louvain-La-Neuve, Belgium, June 30, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy...

New agreement extends GXO and Co‑op’s transport operations partnership to over 20 yearsSupporting deliveries to more than 1,000 stores with shared values to create lasting social value in communities...

The filing application is based on improvements seen across key efficacy endpoints from the global phase III SatraGO-1 and SatraGO-2 studies, including proptosis (bulging eyes) and diplopia (double...